Patents by Inventor Max Maginness

Max Maginness has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220087811
    Abstract: This disclosure provides prosthetic arteriovenous grafts having a blood-contacting layer; an intermediate layer; and a tissue-interface layer formed of a microporous biomaterial with a textured microporous surface, the prosthetic arteriovenous grafts providing vascular access for hemodialysis and being capable of reducing perigraft fibrotic capsular formation, and a method of maintaining the patency of the prosthetic arteriovenous grafts.
    Type: Application
    Filed: December 1, 2021
    Publication date: March 24, 2022
    Inventors: Andrew J. Marshall, Max Maginness, Adrienne Oda, Brandt Scanlan
  • Patent number: 10842916
    Abstract: This disclosure provides a method for reducing or preventing the formation and/or accumulation of drusen in an eye of a mammalian subject in need thereof, the method comprising implanting one or more microporous devices into the eye, each device having a device body and an outer surface, wherein the microporous device is formed of a biocompatible elastomeric material and comprises a plurality of interconnected pores throughout the device body.
    Type: Grant
    Filed: June 24, 2016
    Date of Patent: November 24, 2020
    Assignee: HEALIONICS CORPORATION
    Inventors: Andrew J. Marshall, Max Maginness
  • Patent number: 10751203
    Abstract: Provided herein are implantable devices, such as vascular grafts and access port for hemodialysis, that include a microporous sheath layer having a corrugated outer surface, and use therefore for reducing the risk of infection or stenosis.
    Type: Grant
    Filed: August 13, 2019
    Date of Patent: August 25, 2020
    Assignee: Healionics Corporation
    Inventors: Andrew J. Marshall, Brandt Scanlan, Max Maginness, Adrienne Oda, Michael J. Connolly, Chad MacDonald
  • Publication number: 20190358064
    Abstract: Provided herein are implantable devices, such as vascular grafts and access port for hemodialysis, that include a microporous sheath layer having a corrugated outer surface, and use therefore for reducing the risk of infection or stenosis.
    Type: Application
    Filed: August 13, 2019
    Publication date: November 28, 2019
    Inventors: Andrew J. MARSHALL, Brandt SCANLAN, Max MAGINNESS, Adrienne ODA, Michael J. CONNOLLY, Chad MACDONALD
  • Publication number: 20190321159
    Abstract: This disclosure provides vascular grafts having a textured microporous surface capable of reducing perigraft fibrotic capsular formation, and a method of maintaining the patency of the vascular grafts.
    Type: Application
    Filed: June 28, 2019
    Publication date: October 24, 2019
    Inventors: Andrew J. Marshall, Max Maginness, Adrienne Oda, Brandt Scanlan
  • Patent number: 10420659
    Abstract: Provided herein are implantable devices, such as vascular grafts and access port for hemodialysis, that include a microporous sheath layer having a corrugated outer surface, and use therefore for reducing the risk of infection or stenosis.
    Type: Grant
    Filed: August 25, 2017
    Date of Patent: September 24, 2019
    Assignee: HEALIONICS CORPORATION
    Inventors: Andrew J. Marshall, Brandt Scanlan, Max Maginness, Adrienne Oda, Michael J. Connolly, Chad MacDonald
  • Publication number: 20180055668
    Abstract: Provided herein are implantable devices, such as vascular grafts and access port for hemodialysis, that include a microporous sheath layer having a corrugated outer surface, and use therefore for reducing the risk of infection or stenosis.
    Type: Application
    Filed: August 25, 2017
    Publication date: March 1, 2018
    Inventors: Andrew J. Marshall, Brandt Scanlan, Max Maginness, Adrienne Oda, Michael J. Connolly, Chad MacDonald
  • Publication number: 20160375178
    Abstract: This disclosure provides a method for reducing or preventing the formation and/or accumulation of drusen in an eye of a mammalian subject in need thereof, the method comprising implanting one or more microporous devices into the eye, each device having a device body and an outer surface, wherein the microporous device is formed of a biocompatible elastomeric material and comprises a plurality of interconnected pores throughout the device body.
    Type: Application
    Filed: June 24, 2016
    Publication date: December 29, 2016
    Inventors: Andrew J. Marshall, Max Maginness
  • Publication number: 20150238306
    Abstract: This disclosure provides vascular grafts having a textured microporous surface capable of reducing perigraft fibrotic capsular formation, and a method of maintaining the patency of the vascular grafts.
    Type: Application
    Filed: February 20, 2015
    Publication date: August 27, 2015
    Inventors: Andrew J. Marshall, Max Maginness, Adrienne Oda, Brandt Scanlan
  • Patent number: 8927022
    Abstract: The disclosure provides granular forms of porous biomaterials and methods for forming and applying these biomaterials, including uses to promote vascularization and tissue ingrowth.
    Type: Grant
    Filed: March 3, 2010
    Date of Patent: January 6, 2015
    Assignee: Healionics Corporation
    Inventors: Max Maginness, Andrew Marshall, Christine L. Glaister, Michel Alvarez
  • Patent number: 8647393
    Abstract: This disclosure provides implantable devices coated with microporous surface layers with macrotopographic features that improve bio-integration at the interface of the implantable devices and the surrounding tissue.
    Type: Grant
    Filed: December 18, 2012
    Date of Patent: February 11, 2014
    Assignee: Healionics Corporation
    Inventors: Andrew J. Marshall, Michel Alvarez, Max Maginness
  • Publication number: 20130236502
    Abstract: This disclosure provides implantable devices coated with microporous surface layers with macrotopographic features that improve bio-integration at the interface of the implantable devices and the surrounding tissue.
    Type: Application
    Filed: December 18, 2012
    Publication date: September 12, 2013
    Applicant: HEALIONICS CORPORATION
    Inventors: Andrew J. Marshall, Michel Alvarez, Max Maginness
  • Patent number: 8372423
    Abstract: This disclosure provides implantable devices coated with microporous surface layers with macrotopographic features that improve bio-integration at the interface of the implantable devices and the surrounding tissue.
    Type: Grant
    Filed: April 8, 2011
    Date of Patent: February 12, 2013
    Assignee: Healionics Corporation
    Inventors: Andrew J Marshall, Michel Alvarez, Max Maginness
  • Publication number: 20130022648
    Abstract: The disclosure provides granular forms of porous biomaterials and methods for forming and applying these biomaterials, including uses to promote vascularization and tissue ingrowth.
    Type: Application
    Filed: March 3, 2010
    Publication date: January 24, 2013
    Applicant: HEALIONICS CORPORATION
    Inventors: Max Maginness, Andrew Marshall, Christine L. Glaister, Michel Alvarez
  • Publication number: 20110257623
    Abstract: This disclosure provides implantable devices coated with microporous surface layers with macrotopographic features that improve bio-integration at the interface of the implantable devices and the surrounding tissue.
    Type: Application
    Filed: April 8, 2011
    Publication date: October 20, 2011
    Applicant: HEALIONICS CORPORATION
    Inventors: Andrew J. Marshall, Michel Alvarez, Max Maginness